These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 6427954

  • 1. The physiologic basis of the use of blood and blood products.
    Gould SA, Rice CL, Moss GS.
    Surg Annu; 1984; 16():13-38. PubMed ID: 6427954
    [No Abstract] [Full Text] [Related]

  • 2. Optimal use of blood components and derivatives.
    Walter WJ, Oberman HA.
    Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG, Renger FG.
    Z Arztl Fortbild (Jena); 1983 Aug; 77(19):807-10. PubMed ID: 6417919
    [No Abstract] [Full Text] [Related]

  • 4. Blood products.
    Med Lett Drugs Ther; 1979 Nov 16; 21(23):93-6. PubMed ID: 502967
    [No Abstract] [Full Text] [Related]

  • 5. Current status of erythrocyte substitutes.
    Biro GP.
    Can Med Assoc J; 1983 Aug 01; 129(3):237-44. PubMed ID: 6344974
    [Abstract] [Full Text] [Related]

  • 6. Principles of transfusion medicine perioperatively and in intensive care.
    Höcker P.
    Acta Anaesthesiol Scand Suppl; 1996 Aug 01; 109():137-8. PubMed ID: 8901983
    [No Abstract] [Full Text] [Related]

  • 7. Post-transfusion hepatits following the use of prothrombin complex concentrates.
    Roberts HR, Blatt PM.
    Thromb Diath Haemorrh; 1975 Jun 30; 33(3):610-6. PubMed ID: 1154316
    [No Abstract] [Full Text] [Related]

  • 8. Selected topics in blood component therapy.
    Wallas CH.
    Prog Clin Pathol; 1984 Jun 30; 9():47-64. PubMed ID: 6420839
    [No Abstract] [Full Text] [Related]

  • 9. The place of artificial oxygen carriers in reducing allogeneic blood transfusions and augmenting tissue oxygenation.
    Spahn DR, Kocian R.
    Can J Anaesth; 2003 Jun 30; 50(6 Suppl):S41-7. PubMed ID: 14629052
    [No Abstract] [Full Text] [Related]

  • 10. Artificial blood.
    Squires JE.
    Science; 2002 Feb 08; 295(5557):1002-5. PubMed ID: 11834811
    [Abstract] [Full Text] [Related]

  • 11. [Natural blood and artificial blood in rapid vascular filling].
    Courtine JC, Ement AM.
    Cah Anesthesiol; 1986 May 08; 34(3):205-7. PubMed ID: 3091206
    [No Abstract] [Full Text] [Related]

  • 12. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA.
    Vogel H, Günther H, Harrison DK, Anderer W, Kessler M, Peter K.
    Adv Exp Med Biol; 1989 May 08; 248():653-61. PubMed ID: 2782181
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Indications for blood transfusion].
    Hollán Z.
    Ter Arkh; 1989 May 08; 61(7):113-21. PubMed ID: 2511636
    [No Abstract] [Full Text] [Related]

  • 16. Blood substitutes in surgery.
    Burris D.
    Ann Chir Gynaecol; 2001 May 08; 90(2):76-80. PubMed ID: 11459262
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
    Cohn CS, Cushing MM.
    Crit Care Clin; 2009 Apr 08; 25(2):399-414, Table of Contents. PubMed ID: 19341916
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.